Health Canada drug identification number

DIN 02494388 — MYLOTARG 4.5 MG

MYLOTARG is a powder for solution of Gemtuzumab ozogamicin marketed by PFIZER CANADA ULC. The full Gemtuzumab ozogamicin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02494388
Brand name
MYLOTARG
Active ingredient
Gemtuzumab ozogamicin
Strength
4.5 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Antineoplastic agent - CD33-directed antibody-drug conjugate

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.